Teva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting - Business Wire
Submitted by Anonymous (not verified) on Tue, 04/27/2021 - 12:00
